EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.440
https://www.valueinhealthjournal.com/article/S1098-3015(23)00540-5/fulltext
Title :
EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00540-5&doi=10.1016/j.jval.2023.03.440
First page :
Section Title :
Open access? :
No
Section Order :
11823